

Is Clonazepam still in shortage in 2026? Get the latest update on availability, pricing, and what you can do to find your prescription right now.
If you've had trouble filling your Clonazepam prescription over the past year or two, you're not imagining things. Clonazepam — the generic form of Klonopin — has been in intermittent shortage across the United States since 2023, and the situation continues into 2026.
In this update, we'll cover what's happening with the shortage right now, why it's persisting, what the medication costs, and what you can do to get your prescription filled.
Yes. As of late 2025, the American Society of Health-System Pharmacists (ASHP) continues to list Clonazepam oral tablets as a current drug shortage. Teva — one of the largest generic manufacturers — has reported its 0.5 mg and 2 mg tablets on intermittent back order, releasing supplies as they become available.
The FDA has also acknowledged supply disruptions, and reports from pharmacies across the country confirm that many locations are unable to consistently stock all strengths of Clonazepam.
This doesn't mean Clonazepam is completely unavailable — it means supply is unpredictable, and finding it may require some effort. Availability varies by region, pharmacy, and strength.
Several factors continue to drive the shortage:
As a Schedule IV controlled substance, Clonazepam production is capped by annual DEA quotas. Even when demand rises, manufacturers can only produce as much as the DEA allows. Quota adjustments have not kept pace with patient need.
Clonazepam is made by multiple generic companies, including Teva, Accord, Solco, and Sun Pharma. When any of these manufacturers face production issues — whether from raw material shortages, equipment problems, or regulatory actions — the entire supply chain tightens.
Prescriptions for benzodiazepines have grown in recent years, driven by increasing rates of anxiety and panic disorders. More prescriptions for the same (or less) supply means more patients competing for limited stock.
The pharmaceutical supply chain for generic drugs is surprisingly fragile. Most active pharmaceutical ingredients (APIs) are manufactured overseas, and disruptions at any point — shipping delays, quality issues, regulatory holds — can ripple through to pharmacy shelves.
For a deeper look at the causes, read our article on why Clonazepam is so hard to find.
The silver lining of Clonazepam being a widely available generic is that when you can find it, it's relatively affordable:
However, during periods of acute shortage, some patients have reported paying higher prices at pharmacies that have limited stock. Shopping around and using discount tools can help keep costs down.
For detailed savings strategies, see our guide on how to save money on Clonazepam in 2026.
While there's no magic fix for the shortage, a few developments are worth noting:
Here are practical steps you can take today:
For more detailed strategies, read our guide on how to find Clonazepam in stock near you.
The Clonazepam shortage has been a long and frustrating experience for patients who depend on this medication for seizures, panic disorder, and anxiety. While supply is improving incrementally, the reality is that finding Clonazepam still requires persistence in 2026.
Stay proactive: use tools like Medfinder, work closely with your pharmacy and doctor, and don't wait until you're completely out to start looking for your refill. The situation is improving, but it's not resolved — and your health is too important to leave to chance.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.